Based on our retrospective study, we selected four different TNBC cell lines (two originated from pleural effusion and two from primary tumours) to evaluate whether the activation of the IL-3/IL-3Rα axis impacts TNBC aggressiveness. This evidence concerns the gene IL3 and Pleural effusion.